{"disease":{"id":"idiopathic-parkinson-disease","name":"idiopathic parkinson disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT01215227","title":"An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":839,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01227265","title":"Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":476,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05437003","title":"A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in PD Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":465,"lead_sponsor_name":"NeuraLight","has_results":false},{"nct_id":"NCT03944785","title":"Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)","phase":"","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT07023224","title":"Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)","phase":"","overall_status":"RECRUITING","enrollment_count":130,"lead_sponsor_name":"Izmir Bakircay University","has_results":false},{"nct_id":"NCT03841604","title":"Effect of Safinamide on Parkinson's Disease Related Chronic Pain","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Zambon SpA","has_results":true},{"nct_id":"NCT03665493","title":"Dopamine Effect on Inhibitory Control","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Giovanni Mirabella","has_results":false},{"nct_id":"NCT01668407","title":"Robot Walking Rehabilitation in Parkinson's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"IRCCS San Raffaele Roma","has_results":false},{"nct_id":"NCT05931575","title":"Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":75,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT02723396","title":"Sleep, Awake & Move - Part I","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Neurocenter of Southern Switzerland","has_results":false},{"nct_id":"NCT03051607","title":"Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":66,"lead_sponsor_name":"Biotie Therapies Inc.","has_results":true},{"nct_id":"NCT05687799","title":"Fatigue, Sleep and Quality of Life in Parkinson's Patients","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Nigde Omer Halisdemir University","has_results":false},{"nct_id":"NCT05671341","title":"Comparison of Balance, Activity-specific Balance Confidence and Quality of Life in Parkinson's Patients","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Nigde Omer Halisdemir University","has_results":false},{"nct_id":"NCT03782753","title":"Molecular Pathology and Neuronal Networks in LRRK2 Parkinson's Disease","phase":"","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT00985517","title":"Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Sangamo Therapeutics","has_results":true},{"nct_id":"NCT04459052","title":"FDOPA PET and Nutritional Support in Parkinson's Disease","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT03652363","title":"GDNF in ideopathicParkinsons Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"North Bristol NHS Trust","has_results":false},{"nct_id":"NCT06390163","title":"Effects of Sensory-Motor Integration Training in Patients with Idiopathic Parkinson's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT07015346","title":"Adhesion and Safety of Rotigexole Compared to Neupro®","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Eva Pharma","has_results":false},{"nct_id":"NCT03700684","title":"Voice Treatment for Parkinson's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"University of Massachusetts, Amherst","has_results":true},{"nct_id":"NCT04524143","title":"The Acute Effect of Cervical Mobilization in Parkinson's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT05107531","title":"Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT04524182","title":"The Acute Effect of Lumbosacral Mobilization in Parkinson's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT02710487","title":"Sleep, Awake & Move - Part II","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Neurocenter of Southern Switzerland","has_results":false},{"nct_id":"NCT03683225","title":"A Study to Evaluate in Patients With Parkinsonian Type Disorders","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Chase Therapeutics Corporation","has_results":false},{"nct_id":"NCT04202757","title":"Intravenous Plasma Treatment for Parkinson's Disease","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"The Neurology Center","has_results":false},{"nct_id":"NCT02565628","title":"PF-06669571 In Subjects With Idiopathic Parkinson's Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03065192","title":"Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Neurocrine Biosciences","has_results":false},{"nct_id":"NCT05027620","title":"Feasibility of Motor-cognitive Home Training for Parkinson's Disease Using eHealth Technology","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Stiftelsen Stockholms Sjukhem","has_results":false},{"nct_id":"NCT06556173","title":"Phase 2a Study of VTX3232 in Parkinson's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Zomagen Biosciences Ltd.","has_results":false},{"nct_id":"NCT03968744","title":"Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Alain Kaelin","has_results":false},{"nct_id":"NCT05699161","title":"Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Samuel Vilchez, PhD","has_results":false},{"nct_id":"NCT05094011","title":"Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Taiwan Mitochondrion Applied Technology Co., Ltd.","has_results":false},{"nct_id":"NCT04510922","title":"Lundbeck TOMs Orthostatic Hypotension","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Alberto Espay, MD, MSc","has_results":true},{"nct_id":"NCT05103618","title":"Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Andrew Newberg","has_results":false},{"nct_id":"NCT04101513","title":"The Natural History of Parkinson's Disease-associated Spinal Disorders","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Ohio State University","has_results":false}],"total":38},"guidelines":[],"source":"Drug Landscape verified database"}